Danish HTA (Health Technology Assessment) centre to predict effects of new technology:
This article was originally published in Clinica
Executive Summary
The Danish Centre for Evaluation and Health Technology Assessment is to send alerts not only to leading health professionals but also to politicians and civil servants about the expected consequences for the healthcare sector of new and upcoming technologies. It will assess some 10 technologies a year, according to the newsletter of the Danish medical device industry association (DMDA), and aim to distribute its notices before the technologies are due to be used routinely. The technologies will be assessed in terms of their clinical efficiency, their organisational and economic consequences, and their impact on the daily life of patients.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.